AIHC Capital Management Ltd
Long book
$119.7M
Q1 2026
Positions
5
Top-10 weight
100%
concentration
Last quarter
+61.1%
SPY +14.8%
Turnover
43%
of book per quarter
Strategy in plain words
auto-generated from filingsAIHC Capital Management Ltd is a diversified fundamental manager, specialised in healthcare (100% of the long book), running a $119.7M US long book across 5 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: REVOLUTION MEDICINES INC, ORIC PHARMACEUTICALS INC, NOVABRIDGE BIOSCIENCES, COGENT BIOSCIENCES INC, KORRO BIO INC.
We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q4 2025
+19.6%
Q1 2026
+61.1%
Sector allocation
Healthcare 100%